Effect of self-monitoring intervention for taste disoder of breast cancer patients undergoing chemotherapy

Effect of self-monitoring intervention for taste disoder of breast cancer patients undergoing chemotherapy - Self-monitoring intervention for taste disoder of breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022739

Enrollment

Registered

2018-04-01

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Patients undergoing chemotherapy do self-monitoring of taste every day. Performing the feedback of the self-monitoring on the day of treatment every three weeks. Carry out a questionnaire about the al

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients undergoing preoperative or postoperative adjuvant therapy on an outpatients basis We perform a regimen that includes a 5FU and taxane-based drug, patients produce a taste failure after initial treatment Consent was obtained patients

Exclusion criteria

Exclusion criteria: Patient records and communication is not possible due to Japanese Patients with recurrent treatment

Design outcomes

Primary

Measure	Time frame
In order to acquire the self-management ability to taste failure	—

Secondary

Measure	Time frame
Improvement of breast cancer patient self-management, self-efficacy, QOL	—

Countries

Japan

Contacts

Public ContactTaeko Kinjou

Gunma university hospital Outpatient chemotherapy center

m15711024@gunma-u.ac.jp027-220-8608

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026